Tan AR, Chan N, Kiesel BF, Stein MN, et al. A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies. Cancer Chemother Pharmacol 2022;89:49-58.
PMID: 34669023